LILRB1 and T-cell non-Hodgkin lymphoma: T-cell malignancies have been documented to express HLA-G and LILRB1, including in primary cutaneous CD8 + and CD56 + T-cell lymphomas and peripheral circulating Sézary cells [65, 70].